Advanced Primary Squamous

Related by string. * advancing . Advancing . advanced . ADVANCED : Advanced Micro Devices . rival Advanced Micro . Advanced Metering Infrastructure AMI / pri mary . PRIMARY . primary : Primary Care Trust . Primary Leaving Examinations . Primary Care Trusts / squamous : squamous cell carcinoma SCC . esophageal squamous cell carcinoma . cutaneous squamous cell carcinoma * *

Related by context. Frequent words. (Click for all words.) 53 Postmenopausal Women 52 Elderly Patients 52 PREZISTA r 49 Please respond insightfully 49 Ischemic 49 renal insufficiency 47 Traficet EN 46 subjects 46 RRMS patients 45 NLX P# 45 neoplasms 45 PsA 44 laboratory abnormalities 44 blinded placebo controlled 44 hypocalcemia 44 Solid Tumors 43 mg BID 43 anticholinergics 43 defame threaten abuse 43 Randomized controlled 43 normotensive 43 Pathologic 43 Pharmacokinetic 43 LUTS 43 TYSABRI treated 43 intramuscularly 43 Exclusion criteria 43 mg QD 42 randomized #:# 42 evaluable 42 nonrandomized 42 email letters@usatoday.com 42 Avoid hate speech 42 events AEs 42 Randomized 42 subgroup analyzes 42 Adverse events 42 methylprednisolone 42 Thrombolysis 41 confidence interval CI 41 dose cohorts 41 nonresponders 41 ALL CAPITALS 41 mg kg dose 41 Postoperative 41 concomitant medications 41 analgesic efficacy 41 depression irritability 41 lacosamide 41 % CI #.#-#.# [003] 41 P = .# 41 Secondary endpoints 41 Note Movie showtimes 41 CI = 41 placebo p = 41 mg d 40 pharmacodynamic 40 neurologic symptoms 40 Avoid abusive 40 p = .# [002] 40 aetiology 40 Concomitant 40 EVIZON 40 threatening harassing defamatory 40 naïve 40 Narcissists 40 subcutaneous injections 40 naà ¯ ve 40 CI -#.# 40 ziprasidone 39 Secondary endpoints include 39 etiologies 39 Efficacy 39 Main Outcome Measures 39 Naïve 39 TheSouthern.com encourages readers 39 multivariate analyzes 39 n = 39 Studied 39 dose regimens 39 intellectually inferior 39 dosing regimens 38 preoperatively 38 evaluable patients 38 IPSS 38 neuroanatomy 38 ascending doses 38 blatantly misrepresent 38 efficacy endpoints 38 secondary efficacy endpoints 38 sexual dysfunctions 38 double blinded placebo 38 comorbid conditions 38 cognitively normal 38 treatment emergent adverse 38 Correlates 38 use racial slurs 38 diabetic neuropathy 38 randomized 38 seducers 38 citalopram

Back to home page